Sean Emery

13.0k citations

167 papers · 9.3k indexed · 2 hit papers · h-index 44

Impact in

Virology top 0.1%
- HIV Research and Treatment
Emergency Medicine top 0.05%
- HIV-related health complications and treatments

Papers in

Virology 104
- HIV Research and Treatment 104
Emergency Medicine 65
- HIV-related health complications and treatments 65

Co-authors: Matthew Law Anthony D. Kelleher David A. Cooper Kazuo Suzuki Michael J. Vjecha Andrew Carr Margaret Johnson Jonel Trebicka
Journals: AIDS (26 papers)PLoS ONE (12 papers)The Journal of Infectious Diseases (11 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (9 papers)HIV Medicine (9 papers)
Partner nations: Australia United States United Kingdom

In The Last Decade

Sean Emery

164 papers receiving 9.1k citations

Hit Papers

align trajectories log scale

Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study 2015 · 2.5k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 PLoS ONE
2011 The Journal of Infectious Diseases

Peers

Countries citing papers authored by Sean Emery

Since Specialization

Citations

This map shows the geographic impact of Sean Emery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Emery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Emery more than expected).

Fields of papers citing papers by Sean Emery

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Emery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Emery. The network helps show where Sean Emery may publish in the future.

Co-authors

The 25 scholars most cited alongside Sean Emery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sean Emery Line = papers co-authored together Sean Emery links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality Journal de Mycologie Médicale ·Володимир Нестеренко, Sean Emery, Kun Xi, Nancy Neigus, V. Mondain, Minghao Xie, Lauris Gastaud, Christelle Pomarès, Lilia Hasseine	2021	17
2	Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial Journal of the American Heart Association ·Jason V. Baker, Shweta Sharma, Amit C. Achhra, José Ignacio Bernardino, Johannes R. Bogner, Daniel Duprez, Sean Emery, Brian Gazzard, Aramaki Eiji, Greg Grandits, Andrew Phillips, Siegfried Schwarze, Elsayed Z. Soliman, Stephen A. Spector, Giuseppe Tambussi, Jens Lundgren, (unknown)	2017	48
3	Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection AIDS ·Guiliang Li, Birgit Grund, Edward M. Gardner, Richard Kaplan, Eileen Denning, Nicole Engen, Catherine L. Carey, Fabian Chen, Cordero Aguilar Yanislet, Éric Florence, Jesús Sanz, Sean Emery	2017	73
4	Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals Scientific Reports ·Daniel D. Murray, Kazuo Suzuki, Matthew Law, Jonel Trebicka, Amy Z Yu, Margaret Johnson, Michael J. Vjecha, Anthony D. Kelleher, Sean Emery	2017	25
5	HIV dynamics linked to memory CD4+ T cell homeostasis PLoS ONE ·John M. Murray, John Zaunders, Sean Emery, David A. Cooper, Cecilia Wallseth, Kersten K. Koelsch, Anthony D. Kelleher	2017	9
6	Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study AIDS Research and Human Retroviruses ·Sonja Paramita Schrader, Cecilia L. Moore, Eduardo Gotuzzo, 张怀栓, Adeeba Kamarulzaman, Ploenchan Chetchotisakd, Jean van Wyk, Hedy Teppler, Nagalingeswaran Kumarasamy, Jean‐Michel Molina, Sean Emery, David A. Cooper, Mark Boyd, (unknown)	2016	12
7	Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection PLoS ONE ·Janaki Amin, Mark Boyd, Nagalingeswaran Kumarasamy, Cecilia L. Moore, M Losso, 张怀栓, Lerato Mohapi, Stephen J. Kerr, Annette H. Sohn, Hedy Teppler, Boris Renjifo, Jean‐Michel Molina, Sean Emery, David A. Cooper	2015	31
8	Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings Antiviral Therapy ·Бабичев Игорь Витальевич, Andrew Revell, Ekolojik Tehlike Adina, Raph L Hamers, Н Т Походыло, Roos E. Barth, Annemarie M. J. Wensing, Casey D. Morrow, Robin Wood, Yitayih Dagne, Peter Reiss, M Nelson, Sean Emery, Julio Montaner, H. C. Lane	2013	1
9	Short Communication: HIV Blips While on Antiretroviral Therapy Can Indicate Consistently Detectable Viral Levels Due to Assay Underreporting AIDS Research and Human Retroviruses ·John M. Murray, John Zaunders, Kersten K. Koelsch, Ven Natarajan, Yunden Badralmaa, Mankertz Joachim, Paul Bonik, David A. Cooper, Sean Emery, Anthony D. Kelleher	2013	6
10	Predictors of Limb Fat Gain in HIV Positive Patients Following a Change to Tenofovir-Emtricitabine or Abacavir-Lamivudine PLoS ONE ·Allison Martin, Janaki Amin, Sean Emery, David Baker, Andrew Carr, David A. Cooper, Mark Bloch	2011	14
11	Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection The Journal of Infectious Diseases ·Netanya G. Sandler, Handan Wand, Annelys Roque, Matthew Law, Martha Nason, Daniel E. Nixon, Court Pedersen, Kiat Ruxrungtham, Sharon R. Lewin, Sean Emery, James D. Neaton, Jason M. Brenchley, Steven G. Deeks, Irini Sereti, Daniel C. Douek Hit paper breakdown →	2011	856
12	Pharmacokinetics of Lamivudine and Lamivudine-Triphosphate after Administration of 300 Milligrams and 150 Milligrams Once Daily to Healthy Volunteers: Results of the ENCORE 2 Study Antimicrobial Agents and Chemotherapy ·Laura Else, Akil Jackson, Rebekah Puls, Andrew Hill, Paul Fahey, Enmoore Lin, Alieu Amara, Marco Siccardi, Victoria Watson, John Tjia, Sean Emery, Saye Khoo, David Back, Marta Boffito	2011	28
13	A Novel Chemokine-Receptor-5 (CCR5) Blocker, SCH532706, Has Differential Effects on CCR5 ⁺ CD4 ⁺ and CCR5 ⁺ CD8 ⁺ T Cell Numbers in Chronic HIV Infection AIDS Research and Human Retroviruses ·Sarah Pett, John Zaunders, Michelle Bailey, John M. Murray, 宏和青木, Sean Emery, David A. Cooper, Anthony D. Kelleher	2010	8
14	Evolution of CD4 ⁺ T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological Suppression AIDS Research and Human Retroviruses ·Helen Byakwaga, John M. Murray, Kathy Petoumenos, Anthony D. Kelleher, Matthew Law, Mark Boyd, Sean Emery, Patrick Mallon, David A. Cooper	2009	8
15	Effect of nucleoside reverse transcriptase inhibitors on CD4 T‐cell recovery in HIV‐1‐infected individuals receiving long‐term fully suppressive combination antiretroviral therapy HIV Medicine ·Helen Byakwaga, Jialun Zhou, Kathy Petoumenos, Matthew Law, Mark Boyd, Sean Emery, Wilson Giraldo Mejía, Patrick Mallon	2008	3
16	Project Phidisa: development of clinical research capacity within the South African National Defence Force Current Opinion in HIV and AIDS ·K W Lau, Sean Emery, H. Clifford Lane	2007	1
17	In Vivo, Nucleoside Reverse‐Transcriptase Inhibitors Alter Expression of Both Mitochondrial and Lipid Metabolism Genes in the Absence of Depletion of Mitochondrial DNA The Journal of Infectious Diseases ·Patrick Mallon, Patrick Unemori, HeDongjian, Adrienne Morey, Berk Alp Göksel, Kenneth Williams, Donald J. Chisholm, Katherine Samaras, Sean Emery, Anthony D. Kelleher, David A. Cooper, Andrew Carr, (unknown)	2005	140
18	HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting AIDS ·Chris Duncombe, Stephen J. Kerr, Kiat Ruxrungtham, Gregory J. Dore, Matthew Law, Sean Emery, Joep M. A. Lange, Praphan Phanuphak, David A. Cooper	2005	22
19	Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial AIDS ·Dianne Carey, Handan Wand, Allison Martin, 久留須加須美, Sean Emery, David A. Cooper, Andrew Carr	2005	17
20	A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study AIDS ·Andrew Carr, John Chuah, Fan Liu, Martyn A. French, Jennifer Hoy, Matthew Law, D. Sayer, Sean Emery, David A. Cooper	2000	76

About Sean Emery

Sean Emery is a scholar working on Virology, Emergency Medicine, Infectious Diseases, Transplantation and Epidemiology, having authored 167 papers that have together received 9.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (104 papers), HIV/AIDS drug development and treatment (92 papers), HIV-related health complications and treatments (65 papers), HIV/AIDS Research and Interventions (63 papers), Pneumocystis jirovecii pneumonia detection and treatment (13 papers), Immune Cell Function and Interaction (10 papers), Herpesvirus Infections and Treatments (7 papers) and Bone and Joint Diseases (7 papers). The work is most often cited by research in Virology (4.0k citations), Emergency Medicine (2.9k citations), Infectious Diseases (4.2k citations), Epidemiology (1.5k citations) and Immunology (918 citations). Sean Emery has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Matthew Law, Anthony D. Kelleher, David A. Cooper, Kazuo Suzuki, Michael J. Vjecha, Andrew Carr, Margaret Johnson, Jonel Trebicka, Daniel D. Murray and Deborah Wentworth. Their work appears in journals such as AIDS, PLoS ONE, The Journal of Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes and HIV Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact